chevron_leftBack
As of 14 June 2026, Hemab Therapeutics Holdings, Inc. has a market cap of $1.17B USD, ranking #9841 globally and #2057 in the United States.
It ranks #857 in the Healthcare sector, and #158 in the Biotechnology industry.
Key Stats
Market Cap
$1.17BUSD
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -7.3% | -2.5% | -3.9% | -19% | -19% | -19% |
News
Loading...
COAG Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
COAG
ISIN: US4234941031
Shares Out.:
Shares Outstanding:
46.705M1
Shares Float:
33.257M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
24.98 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
16K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
14K%
|
19.0
|
|
NASDAQ: NTRA
|
$27.6B
2K%
|
-
|
|
NYSE: IQV
|
$26.3B
2K%
|
20.0
|
|
NASDAQ: UTHR
|
$25.03B
2K%
|
20.4
|
|
NASDAQ: MRNA
|
$18.13B
1K%
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
EBR: ARGX
|
$47.84B
4K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.84B
4K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$42.36B
4K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$42.3B
4K%
33.71B CHF
|
37.2
|
|
KRX: 068270
|
$28.11B
2K%
42.76T KRW
|
43.8
|
|
NASDAQ: BNTX
|
$25.69B
2K%
|
-
|
chevron_leftBack